{"id":"W2981827178","doi":"10.1093/ofid/ofz360.729","title":"661. Ibalizumab Efficacy and Safety Through 48 Weeks of Treatment: Results of an Expanded Access Protocol (TMB-311)","year":2019,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Theratechnologies (Canada)","funders":"Samsung","keywords":"Medicine; Tolerability; Regimen; Viral load; Internal medicine; Cohort; Human immunodeficiency virus (HIV); Adverse effect; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003023607,0.0007590406,0.001115281,0.0004680895,0.000542896,0.0007768329,0.0006073626,0.0008522645,0.005843192],"category_scores_gemma":[0.00215224,0.0003757865,0.000772409,0.0005261003,0.0006059561,0.0006493909,0.0005051738,0.001584417,0.00145699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007392854,"about_ca_system_score_gemma":0.001633544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007933197,"about_ca_topic_score_gemma":0.0007609251,"domain_scores_codex":[0.9980302,0.001086495,0.0001764312,0.0002110459,0.0002672556,0.0002285461],"domain_scores_gemma":[0.9985262,0.000310302,0.0003476152,0.0003469274,0.0002089671,0.000259965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7534079,0.06905295,0.008020722,0.0004925861,0.0003843158,0.0002622304,0.0002889137,0.002563412,0.06842143,0.0004056483,0.008455065,0.08824485],"study_design_scores_gemma":[0.1828148,0.6954024,0.07308796,0.0001108793,0.0004817487,0.000524224,0.0001225533,0.003166975,0.02595288,0.0004677429,0.0177805,0.00008749073],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.976035,0.0005047569,0.001665557,0.0001513912,0.00008161984,0.01054938,0.006953286,0.0001699886,0.003889043],"genre_scores_gemma":[0.9496977,0.00057148,0.004904495,0.0005343465,0.0001388144,0.02050236,0.0173104,0.00008210236,0.006258337],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005843192,"threshold_uncertainty_score":0.0195474,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02141321896594533,"score_gpt":0.3497568800188321,"score_spread":0.3283436610528868,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}